About Stevanato Group SpA
Stevanato Group (NYSE:STVN) specializes in the production and distribution of pharmaceutical packaging and drug delivery systems. Its operations span across the development of glass vials, syringes, and diagnostic components, aiming to enhance the efficacy, safety, and delivery of healthcare treatments. Stevanato's projects are dedicated to supporting the pharmaceutical and biotech industries with state-of-the-art solutions for medication administration and storage, focusing on innovation and sustainability to meet the evolving needs of patients and healthcare providers worldwide. The company’s objectives are geared towards expanding its global reach, improving product quality, and contributing to the advancement of the pharmaceutical sector through continuous research and development.
Snapshot
Operations
Products and/or services of Stevanato Group SpA
- EZ-fill Syringes & Vials, a ready-to-fill solution enhancing drug product safety and streamlining the filling process.
- Biotech Solutions, offering advanced containment and delivery systems for biopharmaceuticals.
- Glass Primary Packaging, specializing in cartridges, syringes, and vials for pharmaceutical use.
- SG Alina, an integrated platform for insulin delivery devices supporting diabetes management.
- Vision Inspection Systems, providing high-precision inspection technology for pharmaceutical packaging integrity.
- Engineering Systems, offering tailored solutions for assembly, packaging, and drug delivery devices.
Stevanato Group SpA executive team
- Mr. Franco StevanatoCEO & Executive Chairman
- Mr. Marco Dal LagoChief Financial Officer
- Ms. Lisa MilesChief Communications & Investor Relations Officer
- Ms. Carla CostaChief Human Resources Officer
- Mr. Mauro StocchiChief Business Strategy Officer
- Mr. Michele MonicoPresident of DDS & IVD Business Unit
- Mr. Raffaele PacePresident of Engineering Business Unit